Aeras Global TB Vaccine Foundation, GlaxoSmithKline (GSK) Collaborate on TB Vaccine
10/10/2012 7:41:14 AM
More...
|
Aeras Global TB Vaccine Foundation and Infectious Disease Research Institute (IDRI) Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine
5/10/2012 10:06:47 AM
More...
|
Aeras Global TB Vaccine Foundation and CanSino to Collaborate on TB Vaccine Development
5/7/2012 10:12:39 AM
More...
|
TapImmune Inc. (TPIV) and Aeras Global TB Vaccine Foundation Start Research & Development Collaboration
10/31/2011 10:02:02 AM
More...
|
Aeras Global TB Vaccine Foundation and Crucell N.V. (CRXL) Announce Phase II Clinical Trial Start in Kenya
9/22/2010 11:34:19 AM
More...
|
Aeras Global TB Vaccine Foundation And Crucell N.V. (CRXL) Announce Start of Phase II TB study in South Africa
4/14/2010 10:59:06 AM
More...
|
TapImmune Inc. (TPIV) Signs R&D Collaboration Letter of Intent Agreement With Aeras Global TB Vaccine Foundation
2/1/2010 12:37:30 PM
More...
|
Aeras Global TB Vaccine Foundation And Crucell N.V. (CRXL) Announce Start of TB Infant Study in South Africa
4/28/2009 10:58:05 AM
More...
|
Aeras Global TB Vaccine Foundation and Crucell N.V. (CRXL) Announce TB Vaccine Clinical Trial in Kenya; Promising Vaccine Candidate Advances to Phase II Safety Study in South Africa
10/17/2008 8:18:34 AM
More...
|
Emergent BioSolutions (EBS) and the University of Oxford form Joint Venture to Develop an Advanced Tuberculosis Vaccine with Funding from Wellcome Trust Sanger Institute and Aeras Global TB Vaccine Foundation
7/23/2008 10:09:17 AM
More...
|
|